Evidence map›Paper›PMID 12093690›Full record

ArticleClinical and diagnostic laboratory immunology2002

Use of multiepitope polyproteins in serodiagnosis of active tuberculosis.

Raymond L Houghton, Michael J Lodes, Davin C Dillon, Lisa D Reynolds, Craig H Day, Patricia D McNeill, Ronald C Hendrickson, Yasir A W Skeiky, Diana P Sampaio, Roberto Badaro and 2 more

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Raymond L HoughtonCorixa Corporation, Seattle, Washington 98104, USA. houghton@corixa.com
Michael J Lodes
Davin C Dillon
Lisa D Reynolds
Craig H Day
Patricia D McNeill
Ronald C Hendrickson
Yasir A W Skeiky
Diana P Sampaio
Roberto Badaro
Konstantin P Lyashchenko
Steven G Reed
Corixa Corporation · USUniversidade Federal da Bahia · BRChembio (United States) · US

Funding

A RAPID SERODIAGNOSTIC TEST FOR TUBERCULOSISR44AI043781 · NIAID · CHEMBIO DIAGNOSTIC SYSTEMS, INC. · PI LYASHCHENKO, KONSTANTIN P · 2000 to 2001
$719k
NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSISR43AI039879 · NIAID · CORIXA CORPORATION · PI HOUGHTON, RAYMOND · 1996 to 1996
–
RAPID SERODIAGNOSTIC TEST FOR TUBERCULOSISR43AI043781 · NIAID · CHEMBIO DIAGNOSTIC SYSTEMS, INC. · PI LYASHCHENKO, KONSTANTIN P · 1998 to 1998
–
NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSISR44AI039879 · NIAID · CORIXA CORPORATION · PI HOUGHTON, RAYMOND · 1997 to 1998
–
NIAID NIH HHS AI-39879NIAID NIH HHS AI-43781
6 · The paper itself

Abstract

Screening of genomic expression libraries from Mycobacterium tuberculosis with sera from tuberculosis (TB) patients or rabbit antiserum to M. tuberculosis led to the identification of novel antigens capable of detecting specific antibodies to M. tuberculosis. Three antigens, Mtb11 (also known as CFP-10), Mtb8, and Mtb48, were tested together with the previously reported 38-kDa protein, in an enzyme-linked immunosorbent assay (ELISA) to detect antibodies in TB patients. These four proteins were also produced as a genetically fused polyprotein, which was tested with two additional antigens, DPEP (also known as MPT32) and Mtb81. Sera from individuals with pulmonary and extrapulmonary TB, human immunodeficiency virus (HIV)-TB coinfections, and purified protein derivative (PPD)-positive and PPD-negative status with no evidence of disease were tested. In samples from HIV-negative individuals, the ELISA detected antibodies in >80% of smear-positive individuals and >60% smear-negative individuals, with a specificity of approximately 98%. For this group, smears detected 81.6% but a combination of smear and ELISA had a sensitivity of approximately 93%. The antigen combination detected a significant number of HIV-TB coinfections as well as antibodies in patients with extrapulmonary infections. Improved reactivity in the HIV-TB group was observed by including the antigen Mtb81 that was identified by proteomics. The data indicate that the use of multiple antigens, some of which are in a single polyprotein, can be used to facilitate the development of a highly sensitive test for M. tuberculosis antibody detection.

Indexed as

Antigens, BacterialAntibodies, BacterialEnzyme-Linked Immunosorbent AssayEpitopesGene LibraryHIV InfectionsHumansMycobacterium tuberculosisProtein EngineeringRecombinant Fusion ProteinsSensitivity and SpecificitySerologic TestsTuberculosis, PulmonaryAntibodies, BacterialAntigens, BacterialEpitopesRecombinant Fusion Proteins

Identifiers

PMID12093690
PMCPMC120014
OpenAlexW2134071144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.